ENOV
Enovis Corp
NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES
$19.28
+4.73% today
Updated 2026-09-11
Market cap
$1.07B
P/E ratio
—
P/S ratio
0.47x
EPS (TTM)
$-19.27
Dividend yield
—
52W range
$19 – $34
Volume
1.3M
Enovis Corp (ENOV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$19.28
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$34.86
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.6B | $1.7B | $2.1B | $2.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -48.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.